Fox Chase Cancer Center Adds Gregory Enders, M.D., Ph.D., to Gastroenterology Staff
PHILADELPHIA (Nov. 9, 2006) - Gregory H. Enders, MD, PhD, of Villanova, Pa., has joined Fox Chase Cancer Centers medical oncology department as an attending gastroenterologist. His particular clinical interest is in colorectal cancer, including molecular causes of the disease; chemotherapy for colorectal cancer; and chemoprevention strategies. Chemoprevention is the use of natural or synthetic agents to prevent or slow the onset of disease.
Enders was previously an assistant professor of medicine in the gastroenterology division of the University of Pennsylvania School of Medicine and an attending physician in the gastrointestinal fellows clinic. He held a secondary appointment as assistant professor of genetics at the medical school. He also directed the morphology core facility (focusing on the form and structure of organisms) of the Center for Molecular Studies in Digestive and Liver Diseases at Penn.
After earning his undergraduate degree in biology magna cum laude at Harvard University, Enders received his Ph.D. in genetics at the University of California at San Francisco in 1987 and his M.D. there in 1988. He was also a fellow in the National Institutes of Health Medical Scientist Training Program at UCSF.
Enders completed his residency at Brigham and Womens Hospital in Boston while holding a clinical fellowship in medicine at Harvard Medical School. He then held a fellowship in gastroenterology at Massachusetts General Hospital and a research fellowship in medicine at Harvard.
Board-certified in internal medicine and gastroenterology, Enders served as an instructor in medicine at from 1993 to 1996 and then joined the University of Pennsylvania faculty.
Enders earned a National Cancer Institute Clinical Investigator Award in 1993, an American Cancer Society Research Scholar Award in 1999 and the Miles and Shirley Fiterman Basic Research Award from the American Digestive Health Foundation in 2001. He also received two awards from the University of Pennsylvanias department of medicine, the Barra Foundation New Research Initiative Award in 1997 and the Measey Award in 2000.
Enders has published numerous research papers and given frequent lectures by invitation. He is currently a member of the editorial board of Cancer Biology and Therapy and an associate editor of both Cancer Research and the online BioMed Central journal called Cell Division. Enders is also an ad hoc reviewer for a number of other professional journals.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.